PUBLISHER: 360iResearch | PRODUCT CODE: 1591991
PUBLISHER: 360iResearch | PRODUCT CODE: 1591991
Implantable Drug Delivery Device Market by Product (Bio-absorbable Stent, Brachytherapy Seeds, Coronary Drug-Eluting Stent), Technology (Bio-Degradable, Non-Biodegradable, Smart Pills), Application - Global Forecast 2025-2030
The Implantable Drug Delivery Device Market was valued at USD 19.78 billion in 2023, expected to reach USD 21.53 billion in 2024, and is projected to grow at a CAGR of 8.91%, to USD 35.97 billion by 2030.
The implantable drug delivery device market is defined by its focus on clinical solutions allowing precise, targeted medication delivery over extended periods. These devices are vital due to their ability to enhance drug bioavailability and patient compliance, particularly for chronic diseases like diabetes, cancer, and hormonal disorders. Their applications span from managing pain to administering vaccines, with end-use sectors including hospitals, outpatient services, and home healthcare settings due to increasing emphasis on decentralized patient care. Key growth factors for this market revolve around the evolving global healthcare landscape, which emphasizes personalized medicine and advances in biotechnology like nano-technology and smart polymers, enabling more effective and versatile implantable solutions. Rising incidences of chronic diseases and the aging global population further compound demand. Recent technological opportunities arise with advancements in controlled drug release systems and biodegradable implants. Emerging opportunities include partnerships with biotech firms focused on precision medicine and continuous innovation in material science to improve device compatibility and patient outcomes. However, limitations like the high cost of research and development, stringent regulatory pathways, proving long-term safety, and the threat of surgical complications remain significant challenges. Legal and ethical concerns also pose hurdles, particularly regarding patient privacy in devices with digital monitoring capabilities. For fostering innovation, companies could focus on integrating sensors and AI for real-time patient monitoring, ensuring responsive adjustments to drug delivery, or exploring new biodegradable materials to address environmental concerns associated with medical waste. The nature of the market is rapidly adapting, characterized by a surge in R&D investments and strategic mergers aimed at enhancing product portfolios. Companies should thus invest in cross-disciplinary innovation and forge partnerships that leverage AI and IoT to secure competitive advantages, ensuring adaptability to evolving market demands.
| KEY MARKET STATISTICS | |
|---|---|
| Base Year [2023] | USD 19.78 billion |
| Estimated Year [2024] | USD 21.53 billion |
| Forecast Year [2030] | USD 35.97 billion |
| CAGR (%) | 8.91% |
Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Implantable Drug Delivery Device Market
The Implantable Drug Delivery Device Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.
- Market Drivers
- Growing incidence of chronic conditions, such as cancer and diabetes
- Advances in medication administration techniques
- Adoption of infusion pumps to monitor patient safety and avoid frequent dosage errors
- Market Restraints
- High cost of devices
- Market Opportunities
- Growing adoption of specialty infusion systems
- Rising amalgamation activities for advancement in implantable drug delivery device
- Market Challenges
- Noticeable incidences of product recall due to medical error
Porter's Five Forces: A Strategic Tool for Navigating the Implantable Drug Delivery Device Market
Porter's five forces framework is a critical tool for understanding the competitive landscape of the Implantable Drug Delivery Device Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.
PESTLE Analysis: Navigating External Influences in the Implantable Drug Delivery Device Market
External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Implantable Drug Delivery Device Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.
Market Share Analysis: Understanding the Competitive Landscape in the Implantable Drug Delivery Device Market
A detailed market share analysis in the Implantable Drug Delivery Device Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.
FPNV Positioning Matrix: Evaluating Vendors' Performance in the Implantable Drug Delivery Device Market
The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Implantable Drug Delivery Device Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.
Strategy Analysis & Recommendation: Charting a Path to Success in the Implantable Drug Delivery Device Market
A strategic analysis of the Implantable Drug Delivery Device Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.
Key Company Profiles
The report delves into recent significant developments in the Implantable Drug Delivery Device Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, ALIMERA SCIENCES, INC., B. Braun SE, Baxter International Inc., Bayer AG, Boston Scientific Corporation, Concept Medical, Delpor Inc., ICU Medical, Inc., Koninklijke DSM N.V., Medtronic plc, Merck KGaA, P+F Products + Features GmbH, Teleflex Incorporated, and Teva Pharmaceuticals Industries Ltd..
Market Segmentation & Coverage
This research report categorizes the Implantable Drug Delivery Device Market to forecast the revenues and analyze trends in each of the following sub-markets:
- Based on Product, market is studied across Bio-absorbable Stent, Brachytherapy Seeds, Coronary Drug-Eluting Stent, Drug Infusion Pumps, Implantable Contraceptive Devices, and Implantable Intraocular Devices.
- Based on Technology, market is studied across Bio-Degradable, Non-Biodegradable, and Smart Pills.
- Based on Application, market is studied across Cardiology, Contraceptive, Oncology, and Ophthalmology.
- Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
The report offers a comprehensive analysis of the market, covering key focus areas:
1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.
2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.
3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.
4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.
5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.
The report also answers critical questions to aid stakeholders in making informed decisions:
1. What is the current market size, and what is the forecasted growth?
2. Which products, segments, and regions offer the best investment opportunities?
3. What are the key technology trends and regulatory influences shaping the market?
4. How do leading vendors rank in terms of market share and competitive positioning?
5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?
Table of Contents
1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Stakeholders
2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Growing incidence of chronic conditions, such as cancer and diabetes
- 5.1.1.2. Advances in medication administration techniques
- 5.1.1.3. Adoption of infusion pumps to monitor patient safety and avoid frequent dosage errors
- 5.1.2. Restraints
- 5.1.2.1. High cost of devices
- 5.1.3. Opportunities
- 5.1.3.1. Growing adoption of specialty infusion systems
- 5.1.3.2. Rising amalgamation activities for advancement in implantable drug delivery device
- 5.1.4. Challenges
- 5.1.4.1. Noticeable incidences of product recall due to medical error
- 5.1.1. Drivers
- 5.2. Market Segmentation Analysis
- 5.3. Porter's Five Forces Analysis
- 5.3.1. Threat of New Entrants
- 5.3.2. Threat of Substitutes
- 5.3.3. Bargaining Power of Customers
- 5.3.4. Bargaining Power of Suppliers
- 5.3.5. Industry Rivalry
- 5.4. PESTLE Analysis
- 5.4.1. Political
- 5.4.2. Economic
- 5.4.3. Social
- 5.4.4. Technological
- 5.4.5. Legal
- 5.4.6. Environmental
6. Implantable Drug Delivery Device Market, by Product
- 6.1. Introduction
- 6.2. Bio-absorbable Stent
- 6.3. Brachytherapy Seeds
- 6.4. Coronary Drug-Eluting Stent
- 6.5. Drug Infusion Pumps
- 6.6. Implantable Contraceptive Devices
- 6.7. Implantable Intraocular Devices
7. Implantable Drug Delivery Device Market, by Technology
- 7.1. Introduction
- 7.2. Bio-Degradable
- 7.3. Non-Biodegradable
- 7.4. Smart Pills
8. Implantable Drug Delivery Device Market, by Application
- 8.1. Introduction
- 8.2. Cardiology
- 8.3. Contraceptive
- 8.4. Oncology
- 8.5. Ophthalmology
9. Americas Implantable Drug Delivery Device Market
- 9.1. Introduction
- 9.2. Argentina
- 9.3. Brazil
- 9.4. Canada
- 9.5. Mexico
- 9.6. United States
10. Asia-Pacific Implantable Drug Delivery Device Market
- 10.1. Introduction
- 10.2. Australia
- 10.3. China
- 10.4. India
- 10.5. Indonesia
- 10.6. Japan
- 10.7. Malaysia
- 10.8. Philippines
- 10.9. Singapore
- 10.10. South Korea
- 10.11. Taiwan
- 10.12. Thailand
- 10.13. Vietnam
11. Europe, Middle East & Africa Implantable Drug Delivery Device Market
- 11.1. Introduction
- 11.2. Denmark
- 11.3. Egypt
- 11.4. Finland
- 11.5. France
- 11.6. Germany
- 11.7. Israel
- 11.8. Italy
- 11.9. Netherlands
- 11.10. Nigeria
- 11.11. Norway
- 11.12. Poland
- 11.13. Qatar
- 11.14. Russia
- 11.15. Saudi Arabia
- 11.16. South Africa
- 11.17. Spain
- 11.18. Sweden
- 11.19. Switzerland
- 11.20. Turkey
- 11.21. United Arab Emirates
- 11.22. United Kingdom
12. Competitive Landscape
- 12.1. Market Share Analysis, 2023
- 12.2. FPNV Positioning Matrix, 2023
- 12.3. Competitive Scenario Analysis
- 12.4. Strategy Analysis & Recommendation
Companies Mentioned
- 1. Abbott Laboratories
- 2. ALIMERA SCIENCES, INC.
- 3. B. Braun SE
- 4. Baxter International Inc.
- 5. Bayer AG
- 6. Boston Scientific Corporation
- 7. Concept Medical
- 8. Delpor Inc.
- 9. ICU Medical, Inc.
- 10. Koninklijke DSM N.V.
- 11. Medtronic plc
- 12. Merck KGaA
- 13. P+F Products + Features GmbH
- 14. Teleflex Incorporated
- 15. Teva Pharmaceuticals Industries Ltd.
LIST OF FIGURES
- FIGURE 1. IMPLANTABLE DRUG DELIVERY DEVICE MARKET RESEARCH PROCESS
- FIGURE 2. IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2023 VS 2030
- FIGURE 3. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 5. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
- FIGURE 7. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 8. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
- FIGURE 9. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 10. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
- FIGURE 11. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 12. AMERICAS IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 13. AMERICAS IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 14. UNITED STATES IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 15. UNITED STATES IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 16. ASIA-PACIFIC IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 17. ASIA-PACIFIC IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 18. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 19. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 20. IMPLANTABLE DRUG DELIVERY DEVICE MARKET SHARE, BY KEY PLAYER, 2023
- FIGURE 21. IMPLANTABLE DRUG DELIVERY DEVICE MARKET, FPNV POSITIONING MATRIX, 2023
LIST OF TABLES
- TABLE 1. IMPLANTABLE DRUG DELIVERY DEVICE MARKET SEGMENTATION & COVERAGE
- TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
- TABLE 3. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
- TABLE 4. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
- TABLE 5. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 6. IMPLANTABLE DRUG DELIVERY DEVICE MARKET DYNAMICS
- TABLE 7. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 8. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY BIO-ABSORBABLE STENT, BY REGION, 2018-2030 (USD MILLION)
- TABLE 9. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY BRACHYTHERAPY SEEDS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 10. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY CORONARY DRUG-ELUTING STENT, BY REGION, 2018-2030 (USD MILLION)
- TABLE 11. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG INFUSION PUMPS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 12. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY IMPLANTABLE CONTRACEPTIVE DEVICES, BY REGION, 2018-2030 (USD MILLION)
- TABLE 13. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY IMPLANTABLE INTRAOCULAR DEVICES, BY REGION, 2018-2030 (USD MILLION)
- TABLE 14. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 15. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY BIO-DEGRADABLE, BY REGION, 2018-2030 (USD MILLION)
- TABLE 16. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY NON-BIODEGRADABLE, BY REGION, 2018-2030 (USD MILLION)
- TABLE 17. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY SMART PILLS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 18. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 19. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
- TABLE 20. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY CONTRACEPTIVE, BY REGION, 2018-2030 (USD MILLION)
- TABLE 21. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
- TABLE 22. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2018-2030 (USD MILLION)
- TABLE 23. AMERICAS IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 24. AMERICAS IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 25. AMERICAS IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 26. AMERICAS IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 27. ARGENTINA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 28. ARGENTINA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 29. ARGENTINA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 30. BRAZIL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 31. BRAZIL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 32. BRAZIL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 33. CANADA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 34. CANADA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 35. CANADA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 36. MEXICO IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 37. MEXICO IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 38. MEXICO IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 39. UNITED STATES IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 40. UNITED STATES IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 41. UNITED STATES IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 42. UNITED STATES IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
- TABLE 43. ASIA-PACIFIC IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 44. ASIA-PACIFIC IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 45. ASIA-PACIFIC IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 46. ASIA-PACIFIC IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 47. AUSTRALIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 48. AUSTRALIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 49. AUSTRALIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 50. CHINA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 51. CHINA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 52. CHINA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 53. INDIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 54. INDIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 55. INDIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 56. INDONESIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 57. INDONESIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 58. INDONESIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 59. JAPAN IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 60. JAPAN IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 61. JAPAN IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 62. MALAYSIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 63. MALAYSIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 64. MALAYSIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 65. PHILIPPINES IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 66. PHILIPPINES IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 67. PHILIPPINES IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 68. SINGAPORE IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 69. SINGAPORE IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 70. SINGAPORE IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 71. SOUTH KOREA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 72. SOUTH KOREA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 73. SOUTH KOREA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 74. TAIWAN IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 75. TAIWAN IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 76. TAIWAN IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 77. THAILAND IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 78. THAILAND IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 79. THAILAND IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 80. VIETNAM IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 81. VIETNAM IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 82. VIETNAM IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 83. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 84. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 85. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 86. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 87. DENMARK IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 88. DENMARK IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 89. DENMARK IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 90. EGYPT IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 91. EGYPT IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 92. EGYPT IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 93. FINLAND IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 94. FINLAND IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 95. FINLAND IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 96. FRANCE IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 97. FRANCE IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 98. FRANCE IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 99. GERMANY IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 100. GERMANY IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 101. GERMANY IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 102. ISRAEL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 103. ISRAEL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 104. ISRAEL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 105. ITALY IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 106. ITALY IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 107. ITALY IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 108. NETHERLANDS IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 109. NETHERLANDS IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 110. NETHERLANDS IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 111. NIGERIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 112. NIGERIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 113. NIGERIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 114. NORWAY IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 115. NORWAY IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 116. NORWAY IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 117. POLAND IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 118. POLAND IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 119. POLAND IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 120. QATAR IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 121. QATAR IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 122. QATAR IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 123. RUSSIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 124. RUSSIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 125. RUSSIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 126. SAUDI ARABIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 127. SAUDI ARABIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 128. SAUDI ARABIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 129. SOUTH AFRICA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 130. SOUTH AFRICA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 131. SOUTH AFRICA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 132. SPAIN IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 133. SPAIN IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 134. SPAIN IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 135. SWEDEN IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 136. SWEDEN IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 137. SWEDEN IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 138. SWITZERLAND IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 139. SWITZERLAND IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 140. SWITZERLAND IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 141. TURKEY IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 142. TURKEY IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 143. TURKEY IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 144. UNITED ARAB EMIRATES IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 145. UNITED ARAB EMIRATES IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 146. UNITED ARAB EMIRATES IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 147. UNITED KINGDOM IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 148. UNITED KINGDOM IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 149. UNITED KINGDOM IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 150. IMPLANTABLE DRUG DELIVERY DEVICE MARKET SHARE, BY KEY PLAYER, 2023
- TABLE 151. IMPLANTABLE DRUG DELIVERY DEVICE MARKET, FPNV POSITIONING MATRIX, 2023
